Clinical Trials Directory

Trials / Completed

CompletedNCT02407496

Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Think Now Incorporated · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is develop a new assessment tool for Attention Deficit-Hyperactivity Disorder (ADHD) and to then test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls).

Detailed description

The purpose of this study is to develop a novel approach and software for analyzing electroencephalography (EEG) data to identify biomarkers of ADHD. Then to test the ability of this assessment tool to differentiate between adults with ADHD and healthy controls by comparing the classification accuracy of the metrics from the new tool to the classification accuracy of existing behavioral tests for ADHD.

Conditions

Interventions

TypeNameDescription
OTHERBehavioral assessment and NAT EEG testsIndividuals in both groups are asked to perform standard behavioral tests and an electroencephalography (EEG) test.

Timeline

Start date
2014-06-01
Primary completion
2015-07-01
Completion
2015-09-01
First posted
2015-04-03
Last updated
2020-12-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02407496. Inclusion in this directory is not an endorsement.

Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD) (NCT02407496) · Clinical Trials Directory